Spark Therapeutics to Participate in Multiple Conferences in March
Additionally, company management will present at the following business or scientific conferences:
Jeffrey D. Marrazzo, chief executive officer, will participate in a panel discussion on gene therapy at the Rare Disease Day at National Institutes of Health(NIH) event on Thursday, March 1, at 1:15 p.m. ET, in the Masur Auditoriumin Building 10 on the main NIH campus in Bethesda, Md. Katherine A. High, M.D., president and head of research and development, will present at the 2018 Thrombosis and Hemostasis Summit of North America(THSNA 2018) on “Contemporary Gene Therapy in Hemostasis and Thrombosis,” on Thursday, March 8, at 9:15 a.m. PT, at the Marriott Marquis in San Diego Jeffrey D. Marrazzo, chief executive officer, will participate in a fireside chat at the Global Philadelphia Association’s 15th Annual Global Business Conferenceon Wednesday, March 14, at 11:15 a.m. ET, at the LeBow College of Businessat Drexel Universityin Philadelphia Jeffrey D. Marrazzo, chief executive officer, will present at the Cowen & Company38th Annual Healthcare Conference on Monday, March 12, at 4:10 p.m. ET, at the Boston Marriott Copley Placein Boston. To access a live audio webcast of Marrazzo’s presentation, please visit http://wsw.com/webcast/cowen46/once/.
- Company management will present at the
Barclays Capital Global Healthcare Conferenceon Thursday, March 15, at the Loews Miami Beach Hotelin Miami. Presentation scheduled for 1:35 p.m. ET.
About Spark Therapeutics
|Investor Contact:||Media Contact:|
|Ryan Asay||Monique da Silva|
|(215) 239-6424||(215) 282-7470|
Source: Spark Therapeutics, Inc.